Maria E. Gadea-Carcelen

Valencia, VC 46014, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: April 15, 2026

Diagnostic approach for multiple sclerosis: optimizing algorithms for intrathecal synthesis of immunoglobulins.

Diagnostic approach for multiple sclerosis: optimizing algorithms for intrathecal synthesis of immunoglobulins.

Journal: Laboratory medicine

Published: December 20, 2024

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.

Journal: Frontiers in neurology

Published: July 11, 2022

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.

Journal: Journal of neurology

Published: December 02, 2021

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain.

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain.

Journal: Frontiers in neurology

Published: June 18, 2021

Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis.

Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis.

Journal: Multiple sclerosis and related disorders

Published: September 17, 2019

Functional and structural changes in the visual pathway in multiple sclerosis.

Functional and structural changes in the visual pathway in multiple sclerosis.

Journal: Brain and behavior

Published: September 09, 2019

The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis.

The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis.

Journal: Transfusion

Published: September 27, 2018

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: December 14, 2016

Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.

Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.

Journal: European neurology

Published: June 30, 2016

Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.

Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.

Journal: European neurology

Published: March 30, 2016

Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis.

Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 23, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026